In re Novartis and Par Antitrust Litig., No. 18-cv-04361 (S.D.N.Y.)

In re Novartis and Par Antitrust Litig., No. 18-cv-04361 (S.D.N.Y.)

In the Exforge case, Faruqi & Farqui represents a pharmaceutical wholesaler and a proposed class of direct purchasers of the hypertension drug, Exforge.  The complaint alleges that Novartis entered into a reverse payment agreement with Par to delay Par’s generic launch.  In exchange, Novartis promised not to launch an authorized generic version of Exforge for the first 180 days Par was on the market.

Details
Filed On: June 22, 2018
Counsel
Joseph T. Lukens
jlukens@faruqilaw.com
Phone (215) 277-5770
Fax (215) 277-5771
Peter Kohn
pkohn@faruqilaw.com
Phone (215) 277-5770
Fax (215) 277-5771
Office
Pennsylvania
1617 JFK Boulevard, Suite 1550 Philadelphia Pennsylvania 19103
Phone (215) 277-5770
Fax (215) 277-5771

Our Offices

Our offices are nationwide. If you have any questions about a case or our firm, please contact us.
Send Us a Message
New York
685 Third Avenue 26th Floor
New York New York 10017
(877) 247-4292 / (212) 983-9330
(212) 983-9331
Los Angeles
1901 Avenue of the Stars Suite 1060
Los Angeles California 90067
(424) 256-2884
(424) 256-2885
Atlanta
3565 Piedmont Road NE Building Four, Suite 380
Atlanta Georgia 30305
(404) 847-0617
(404) 506-9534
Philadelphia
1617 JFK Boulevard, Suite 1550 Philadelphia
Pennsylvania 19103
(215) 277-5770
(215) 277-5771